According to the latest research by SkyQuest Technology, the Global Advanced Wound Care Market was valued at USD 6,500 Million in 2021, and it is expected to reach USD 16,800 Million by 2027, with a CAGR of 5.3% during the forecast period of 2020 – 2027. The research provides an up-to-date analysis of the current market landscape, latest trends, drivers, and overall market environment.
Advanced wound care products are used to treat both acute and chronic wounds. Advanced wound care is becoming more common as a treatment option for chronic wounds, as chronic wounds are costly and take longer to heal. Traditional wound care solutions are being phased out in favor of advanced wound care products, which are more efficient and effective at managing wounds and allowing for speedier healing.
Advanced wound care products aid in maintaining a hydrated environment, controlling temperature, and flow of oxygen, protecting the damaged site from external infection, and reducing discomfort associated with dressing changes. Some of the popular advanced wound care products are hydrocolloids, hydrogels, film and foam dressings, and alginates among others. One of the major aspects driving the demand for advanced wound care solutions is the rising occurrence of chronic injuries. And for the healing of chronic injuries, advanced care products such as films, gauze, hydrogel, hydrocolloid, and foam dressings are vital; which is positively influencing the market growth.
For an effective and early recovery, patients opt for urgent and efficient treatment of chronic wounds including diabetic foot ulcers, venous leg ulcers, and pressure ulcers among others. Active wound care solutions, including biological skin analogs, have been proven to be effective in the treatment of chronic wounds that are difficult to heal. With an inclination towards effective and faster recovery products, the players are likely to shift towards the development of advanced wound care and novel bioactive products. For an instance, Olaregen Therapeutix leverages its customers with an advanced Excellagen Wound Conforming Matrix 3.0 cc pre-filled syringe. Excellagen is a Cellular Tissue Product that has been approved by the FDA for the treatment of wounds such as diabetic foot ulcers, venous leg ulcers, and others. As a result, the launch of improved active medicines by market participants has aided industry growth. Similarly, a growing number of players are getting into the development and launch of such advanced wound care products and gaining a competitive edge in the market.
Buy Now: https://skyquestt.com/buy-now/advanced-wound-care-market
Read market research report, “Global Advanced Wound Care Market Segmented By Product (Dressings (Foam, Hydrocolloid, Film, Alginate), NPWT, Debridement Devices, Grafts, Matrices, and Topical Agents) By Wound Type (Surgical, Traumatic, Ulcers, and Burns) By End-User (Hospital and Homecare) & By Region – Forecast And Analysis 2021-2027” by SkyQuest
The market is characterized by the presence of various well-established players. New product launches, partnerships, and investing in research & development have been key business strategies. The major players in the market are 3M Company (US), Smith & Nephew plc (UK), ConvaTec Group Plc (UK), Coloplast A/S (Denmark), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Holdings Corporation (US), PAUL HARTMANN AG (Germany), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (US), and Organogenesis Holdings Inc. (US) among others.
The wound care sector is projected to be positively influenced by technological improvements done by the key players operating in the market. For instance, in February 2019, Axio Biosolutions launched MaxioCel, the next-generation wound dressing. MaxioCel is a chitosan-based product that is used to treat chronic wounds. Further, in January 2019, the Platform Wound Dressing (PWD), a negative pressure wound therapy (NPWT) device that removes the usage of foam dressings launched by Applied Tissue Technologies LLC received FDA approval. As a result of increased investment in R&D and the development of advanced wound care solutions by market players, the market is likely to propel in the upcoming years.
The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.
Report Findings
- Drivers- The advent of active therapies for the treatment and management of wounds is likely to drive the global advanced wound care industry forward.
- Restraint- High cost associated with wound treatment and management therapies and devices is projected to limit the industry growth.
What does this Report Deliver?
- Market Estimation for 20+ Countries
- Customization on Segments, Regions, and Company Profiles
- 100+ tables, 150+ Figures
- Global and Country Market Trends
- Comprehensive Mapping of Industry Parameters
- Attractive Investment Proposition
- Competitive Strategies Adopted by Leading Market Participants
- Market drivers, restraints, opportunities, and their impact on the market
- Market growth rate till 2027
- Global and Country Market trends
- Regulatory scenario, regional dynamics, and insights of leading countries in each region
- Segment trends and analysis
- Opportunity analysis by region and country
- Segment opportunity and growth
- Porter’s five force analysis to know the market’s condition
- Pricing analysis
- Parent market analysis
- Product portfolio benchmarking
SkyQuest has segmented the Global Advanced Wound Care Market based on Product, Wound Type, End-User, and Region:
- Global Advanced Wound Care Market By Product (Revenue, USD Million, 2020 – 2027)
- Dressings
- Foam
- Hydrocolloid
- Film
- Alginate
- NPWT
- Debridement Devices
- Grafts
- Matrices
- Topical Agents
- Dressings
- Global Advanced Wound Care Market By Wound Type (Revenue, USD Million, 2020 – 2027)
- Surgical
- Traumatic
- Ulcers
- Burns
- Global Advanced Wound Care Market By End-User (Revenue, USD Million, 2020 – 2027)
- Hospital
- Homecare
- Global Advanced Wound Care Market By Region (Revenue, USD Million, 2020 – 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Central & South America
- Brazil
- Rest of CSA
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA
- North America
List of Key Players of Advanced Wound Care Market
- 3M Company (US)
- Smith & Nephew plc (UK)
- ConvaTec Group Plc (UK)
- Coloplast A/S (Denmark)
- Mölnlycke Health Care AB (Sweden)
- Integra LifeSciences Holdings Corporation (US)
- PAUL HARTMANN AG (Germany)
- B. Braun Melsungen AG (Germany)
- Cardinal Health Inc. (US)
- Organogenesis Holdings Inc. (US)
Speak With our Analyst: https://skyquestt.com/speak-with-analyst/advanced-wound-care-market
About Us:
We partner with the world’s most ambitious companies to accelerate growth with breakthrough insights and technology.
Our team is passionate about demystifying dark data and unravel insights that can keep you one step ahead of competition. We connect innovation and technology to new market networks & collaborators for accelerating growth and aligning towards organization’s sustainability goals.
We work with diverse stakeholders from Fortune 1000 companies, Startups, SMEs, Development agencies & Government to help them access hidden data, insights and technologies.
Contact Us:
SkyQuest Technology Consulting Pvt. Ltd.
info@skyquestt.com
USA (+1) 617-230-0741
